Albert Pakhung Li
Currently President and CEO of various interrelated companies: Advanced Pharmaceutical Sciences Inc., Columbia, Maryland; In Vitro ADMET Laboratories Inc., Columbia, Maryland; Brival Inc., Vancouver, British Columbia; ALIVE LLC, Albuquerque, New Mexico. Expertise in the application of human-based in vitro experimental systems in the evaluation of drug properties: pharmacology; drug metabolism; drug-drug interactions; toxicology. Publications include over 150 research articles, review papers and book chapters. Editor of six books. Associate Editor of Current Drug Metabolism. Section Editor of Chemico-Biological Interactions. Editorial Board of various journals in drug metabolism and toxicology. Previous positions include President and CEO, Phase I Molecular Toxicology Inc., Santa Fe, New Mexico; Chief Scientific Officer, In Vitro Technologies Inc. (now Celsis), Baltimore, Maryland; Research Professor and Director, St. Louis University Medical School, St. Louis, Missouri; Senior Fellow, Monsanto Company, St. Louis, Missouri; Group Leader, Cellular and Genetic Toxicology, Lovelace Respiratory Research Institute, Albuquerque, New Mexico; Research Scientist and Assistant Professor, Cancer Research and Treatment Center, Albuquerque, New Mexico. Ph. D. (1976) in Biomedical Sciences, Oak Ridge Graduate School of Biomedical Sciences, University of Tennessee, Knoxville.
Biography Updated on 1 November 2010